REQUEST A DEMO
Total
USD $0.00
Search more companies

"Hurtap" S.A. (Poland)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: "Hurtap" S.A. Profile Updated: August 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Hurtap S.A. is a company operating for 26 years in the pharmaceutical market. The company's activities focus on the distribution of medicines and medical supplies to pharmacies across Poland. Hurtap has an extensive distribution network with warehouses in Leczyca, Glogow, Tychy, Gdansk and Lomza. Hurtap is also a strategic shareholder of MultiPharme S.A. Company's headquarters and main distribution center are located in Leczyca.

Headquarters
Ul. Gornicza 2
Leczyca; Lodzkie; Postal Code: 99-100

Contact Details: Purchase the "Hurtap" S.A. report to view the information.

Website: http://www.hurtap.com.pl

Basic Information
Total Employees:
Purchase the "Hurtap" S.A. report to view the information.
Outstanding Shares:
Purchase the "Hurtap" S.A. report to view the information.
Registered Capital:
Purchase the "Hurtap" S.A. report to view the information.
Financial Auditors:
Purchase the "Hurtap" S.A. report to view the information.
Incorporation Date:
June 28, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after "Hurtap" S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
7.47%
Total operating revenue
8.33%
Operating profit (EBIT)
194.56%
EBITDA
140.03%
Net Profit (Loss) for the Period
218.6%
Total assets
11.43%
Total equity
7.83%
Operating Profit Margin (ROS)
1.32%
Net Profit Margin
0.24%
Return on Equity (ROE)
4.8%
Debt to Equity Ratio
-0.86%
Quick Ratio
0.03%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?